Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 226 - 250 of 352
PLAP Alternative Name Placental Alkaline Phosphatase Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PLAP IHC Disease Germ cell neoplasms, seminoma, dysgerminoma, and germinoma of
PMS2 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MSI Disease Colorectal cancersPMS2 is a component of the DNA mismatch repair system/ The PMS2 gene (on chromosome 7) encodes an
PR Alternative Name Progesterone Receptor, PgR Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PR IHC Disease Breast cancerPR belongs to the superfamily of steroid hormone receptors,
PSA Alternative Name Prostate Specific Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PSA IHC Disease Prostate cancerMarker of glandular epithelium in normal and neoplastic
PSAP Alternative Name Prostate Specific Acid Phosphatase Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PSAP IHC Disease Differentiates between prostatic and urothelial carcinomas/Differentiates
PSMA Alternative Name Prostate Specific Membrane Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PSMA IHC Disease Metastatic prostate carcinomaType II transmembrane glycoprotein
RCC Alternative Name Renal Cell Carcinoma 1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes RCC IHC Disease Renal cell carcinomaAnti renal cell carcinoma (RCC) antibodies detect a
Reticulin Alternative Name Reticular Nuclear Fast Red Stain Methodology Special Stains Test Description Probes/Genes RETIC SS Disease Outlines architecture of liver and spleen,hemangiopericytoma, vascular
S-100 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes S100 IHC Disease Marker of schwann cells and melanocyte, nerve sheath tumors, melanoma, and Langerhans cell histiocytosisFamily
SMMS-1 Alternative Name Smooth Muscle Myosin, Heavy Chain, SMMHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SMMS IHC Disease Distinguish benign breast lesions and carcinoma in
SOX-10 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SOX-10 IHC Disease Melanoma marker, soft tissue tumors of neural crest originTranscription factor known to be crucial in the
SOX11 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SOX11 IHC Disease Mantle cell lymphomaSOX11 is a transcription factor that is normally expressed in the fetal brain and has also
STAT6 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes stat6 IHC Disease Distinction of solitary fibrous tumorSignal transducer and activator of transcription (STAT) 6/Member of STAT
Synaptophysin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SYNAPT IHC Disease Identification of neuronal tumors and tumors with neuroendocrine differentiationA protein (38 kD),
TdT Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TDT IHC Disease Differentiating precursor lymphoid neoplasms, from other small blue cell tumors. Identifying clusters of thymocytes
Thrombomodulin (TM) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes THROM IHC Disease Mesothelioma, Squamous Cell Carcinoma, Urothelial Carcinoma.Also called CD141. Thrombomodulin
Thyroglobulin (TGB) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes THYRO IHC Disease Classification of thyroid carcinomaLarge glycoprotein (MW 670K) produced by thyroid follicular
TIA-1 Alternative Name T-cell Intracytoplasmic Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TIA1 IHC Disease Neoplasms of cytotoxic T cells or natural killer cellsTIA-I
TRAP Alternative Name Tartrate Resistant Acid Phosphatase Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TRAP IHC Disease Hairy cell leukemia, mantle cell lymphoma, splenic marginal
Trichrome Methodology Special Stains Test Description Probes/Genes TRI SS Disease Collagen and smooth muscle in tumors, cirrhosisStains collagen blue
TTF-1 Alternative Name Thyroid Transcription Factor Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TTF1 IHC Disease Distinguish primary and metastatic lung carcinoma from non lung
Uroplakin II Methodology Immunohistochemistry (IHC) Test Description Probes/Genes UROPII IHC Disease Urothelial lesions/Ovarian Brenner tumorTransmembrane protein expressed by urothelial lining cells (umbrella
Uroplakin III Methodology Immunohistochemistry (IHC) Test Description Probes/Genes UROPIII IHC Disease Urothelial lesions/Ovarian Brenner tumorTransmembrane protein expressed by urothelial lining cells
Vimentin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes VIMENT IHC Disease fibrosarcomas, liposarcomas, malignant fibrous histocytomas, angiosarcomas, chondrosarcomas and lymphomasVimentin
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.